31 related articles for article (PubMed ID: 38522807)
1. The novel SMYD3 inhibitor EM127 impairs DNA repair response to chemotherapy-induced DNA damage and reverses cancer chemoresistance.
Sanese P; De Marco K; Lepore Signorile M; La Rocca F; Forte G; Latrofa M; Fasano C; Disciglio V; Di Nicola E; Pantaleo A; Bianco G; Spilotro V; Ferroni C; Tubertini M; Labarile N; De Marinis L; Armentano R; Gigante G; Lantone V; Lantone G; Naldi M; Bartolini M; Varchi G; Del Rio A; Grossi V; Simone C
J Exp Clin Cancer Res; 2024 May; 43(1):151. PubMed ID: 38812026
[TBL] [Abstract][Full Text] [Related]
2. YTHDF1 promotes breast cancer cell growth, DNA damage repair and chemoresistance.
Sun Y; Dong D; Xia Y; Hao L; Wang W; Zhao C
Cell Death Dis; 2022 Mar; 13(3):230. PubMed ID: 35279688
[TBL] [Abstract][Full Text] [Related]
3. IGF-I protects porcine granulosa cells from hypoxia-induced apoptosis by promoting homologous recombination repair through the PI3K/AKT/E2F8/RAD51 pathway.
Liu Z; Feng C; Li C; He T; Wu G; Fu C; Li H; Shen M; Liu H
FASEB J; 2024 Jan; 38(1):e23332. PubMed ID: 38095232
[TBL] [Abstract][Full Text] [Related]
4. E2F8 confers cisplatin resistance to ER+ breast cancer cells via transcriptionally activating MASTL.
Tian J; Lin Y; Yu J
Biomed Pharmacother; 2017 Aug; 92():919-926. PubMed ID: 28605876
[TBL] [Abstract][Full Text] [Related]
5. Prevention of DNA Replication Stress by CHK1 Leads to Chemoresistance Despite a DNA Repair Defect in Homologous Recombination in Breast Cancer.
Meyer F; Becker S; Classen S; Parplys AC; Mansour WY; Riepen B; Timm S; Ruebe C; Jasin M; Wikman H; Petersen C; Rothkamm K; Borgmann K
Cells; 2020 Jan; 9(1):. PubMed ID: 31963582
[TBL] [Abstract][Full Text] [Related]
6. Transcription Factor E2F8 Promotes Cisplatin Resistance in Hepatocellular Carcinoma by Regulating DNA Damage via NUSAP1.
Kong J; Xu S; Zhang P; Wang Y
Int J Toxicol; 2023; 42(5):420-429. PubMed ID: 37331996
[TBL] [Abstract][Full Text] [Related]
7. E2F8-CENPL pathway contributes to homologous recombination repair and chemoresistance in breast cancer.
Wang S; Xia Y; Sun Y; Wang W; Shan L; Zhang Z; Zhao C
Cell Signal; 2024 Jun; 118():111151. PubMed ID: 38522807
[TBL] [Abstract][Full Text] [Related]
8. RNA methylation, homologous recombination repair and therapeutic resistance.
Bai Y; Zhao H; Liu H; Wang W; Dong H; Zhao C
Biomed Pharmacother; 2023 Oct; 166():115409. PubMed ID: 37659205
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic exploitation of tumor cell defects in homologous recombination.
Powell SN; Kachnic LA
Anticancer Agents Med Chem; 2008 May; 8(4):448-60. PubMed ID: 18473729
[TBL] [Abstract][Full Text] [Related]
10. An insight into understanding the coupling between homologous recombination mediated DNA repair and chromatin remodeling mechanisms in plant genome: an update.
Banerjee S; Roy S
Cell Cycle; 2021 Sep; 20(18):1760-1784. PubMed ID: 34437813
[TBL] [Abstract][Full Text] [Related]
11. Homologous recombination deficiency in breast cancer: Implications for risk, cancer development, and therapy.
Ali RMM; McIntosh SA; Savage KI
Genes Chromosomes Cancer; 2021 May; 60(5):358-372. PubMed ID: 33247475
[TBL] [Abstract][Full Text] [Related]
12. Chromatin dynamics during repair of chromosomal DNA double-strand breaks.
Sinha M; Peterson CL
Epigenomics; 2009 Dec; 1(2):371-85. PubMed ID: 20495614
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
